Search Results - "Glaessgen, Daria"

Strong synergy with APR-246 and DNA-damaging drugs in primary cancer cells from patients with TP53 mutant High-Grade Serous ovarian cancer by Fransson, Åsa, Glaessgen, Daria, Alfredsson, Jessica, Wiman, Klas G, Bajalica-Lagercrantz, Svetlana, Mohell, Nina

“…Mutation in the tumor suppressor gene TP53 is an early event in the development of high-grade serous (HGS) ovarian cancer and is identified in more than 96 %…”
Get full text

Abstract 1639: Strong synergy with APR-246 and DNA-damaging drugs in primary ovarian cancer cells by Fransson, Åsa, Glaessgen, Daria, Alfredsson, Jessica, Wiman, Klas G., Bajalica Lagercrantz, Svetlana, Mohell, Nina

“…Background: Mutations in the TP53 gene occur in at least 60% of ovarian tumors and are associated with chemoresistance and poor prognosis. APR-246 (PRIMA-1MET)…”
Get full text

Mesothelin Expression in Patients with High-Grade Serous Ovarian Cancer Does Not Predict Clinical Outcome But Correlates with CD11c+ Expression in Tumor by Magalhaes, Isabelle, Fernebro, Josefin, Abd Own, Sulaf, Glaessgen, Daria, Corvigno, Sara, Remberger, Mats, Mattsson, Jonas, Dahlstrand, Hanna

“…Introduction Mesothelin (MSLN) is overexpressed in several tumors including ovarian cancer and is the target of current trials. There is limited and…”
Get full text